SuRo Capital Corp. (SSSS)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	203	137	99	108	373	261
Market Cap Growth	1.47%	38.40%	-7.75%	-71.11%	42.98%	126.58%
Enterprise Value	260	179	100	142	265	238
Last Close Price	8.49	5.72	3.83	3.69	12.44	7.21
PE Ratio	-	-	19.60	-	2.53	3.46
Forward PE	-	4.02	4.02	4.02	4.02	6.96
PS Ratio	54.62	29.41	15.06	31.15	253.40	142.90
PB Ratio	1.28	0.87	0.49	0.51	1.02	0.86
P/TBV Ratio	1.29	0.87	0.49	0.51	1.02	0.86
P/OCF Ratio	-	58.01	41.68	-	2.03	-
EV/Sales Ratio	71.31	38.20	15.10	40.98	180.15	130.53
Debt / Equity Ratio	0.47	0.47	0.36	0.35	0.20	0.13
Asset Turnover	0.02	0.02	0.02	0.01	0.00	0.01
Quick Ratio	10.33	46.82	73.28	56.17	8.13	0.33
Current Ratio	10.91	46.96	74.12	57.66	8.23	0.34
Return on Equity (ROE)	-9.96%	-21.13%	2.45%	-45.98%	44.14%	30.04%
Return on Assets (ROA)	-2.41%	-2.21%	-1.77%	-1.64%	-1.23%	-1.99%
Return on Capital (ROIC)	-2.42%	-2.22%	-1.77%	-1.69%	-1.48%	-2.64%
Earnings Yield	-8.32%	-27.73%	5.10%	-122.76%	39.46%	28.90%
Dividend Yield	11.78%	-	-	2.98%	64.32%	9.02%
Payout Ratio	-	-	2.83%	-	70.34%	19.46%
Buyback Yield / Dilution	7.97%	8.85%	12.66%	-12.20%	-22.80%	5.54%
Total Shareholder Return	19.73%	8.85%	12.66%	-9.22%	41.52%	14.56%

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q